Evidence map›Paper›PMID 34075367›Full record

ArticleJournal of migration and health2021

Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: A national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees.

Anna Deal, Sally E Hayward, Mashal Huda, Felicity Knights, Alison F Crawshaw, Jessica Carter, Osama B Hassan, Yasmin Farah, Yusuf Ciftci, May Rowland-Pomp and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of migration and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Anna DealThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Sally E HaywardThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Mashal HudaThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Felicity KnightsThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Alison F CrawshawThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Jessica CarterThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Osama B HassanThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Yasmin FarahThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Yusuf CiftciDoctors of the World UK (Médecins du Monde), London, UK.
May Rowland-PompThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Kieran RustageThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Lucy GoldsmithThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
Monika HartmannDoctors of the World UK (Médecins du Monde), London, UK.
Sandra Mounier-JackDepartment of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Rachel BurnsCentre for Public Health Data Science, Institute of Health Informatics, University College London, UK.
Anna MillerDoctors of the World UK (Médecins du Monde), London, UK.
Fatima WurieHealth Improvement Directorate, Public Health England, London, UK.
Ines Campos-MatosHealth Improvement Directorate, Public Health England, London, UK.
Azeem MajeedDepartment of Primary Care & Public Health, Imperial College London, London, UK.
Sally HargreavesThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, UK.
ESCMID Study Group for Infections in Travellers and Migrants (ESGITM)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEarly evidence confirms lower COVID-19 vaccine uptake in established ethnic minority populations, yet there has been little focus on understanding vaccine hesitancy and barriers to vaccination in migrants. Growing populations of precarious migrants (including undocumented migrants, asylum seekers and refugees) in the UK and Europe are considered to be under-immunised groups and may be excluded from health systems, yet little is known about their views on COVID-19 vaccines specifically, which are essential to identify key solutions and action points to strengthen vaccine roll-out.

methodsWe did an in-depth semi-structured qualitative interview study of recently arrived migrants (foreign-born, >18 years old; <10 years in the UK) to the UK with precarious immigration status between September 2020 and March 2021, seeking their input into strategies to strengthen COVID-19 vaccine delivery and uptake. We used the 'Three Cs' model (confidence, complacency and convenience) to explore COVID-19 vaccine hesitancy, barriers and access. Data were analysed using a thematic framework approach. Data collection continued until data saturation was reached, and no novel concepts were arising. The study was approved by the University of London ethics committee (REC 2020.00630).

resultsWe approached 20 migrant support groups nationwide, recruiting 32 migrants (mean age 37.1 years; 21 [66%] female; mean time in the UK 5.6 years [SD 3.7 years]), including refugees (

conclusionsPrecarious migrants may be hesitant about accepting a COVID-19 vaccine and face multiple and unique barriers to access, requiring simple but innovative solutions to ensure equitable access and uptake. Vaccine hesitancy and low awareness around entitlement and relevant access points could be easily addressed with clear, accessible, and tailored information campaigns, co-produced and delivered by trusted sources within marginalised migrant communities. These findings have immediate relevance to the COVID-19 vaccination initiatives in the UK and in other European and high-income countries with diverse migrant populations.

fundingNIHR.

Identifiers

PMID34075367
PMCPMC8154190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.